Join
Live feed
·
PRReleasevia Quantisnow
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

ByQuantisnow·Wall Street's wire, on your screen.
CRDL· Cardiol Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRDL (Cardiol Therapeutics Inc.) and more on Quantisnow.